Chromoblastomycosis

Chromoblastomycosis
ICD-10	B43
ICD-9	117.2
DiseasesDB	29799
eMedicine	derm/855
MeSH	D002862

Chromoblastomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gastritis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
Endoscopy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chromoblastomycosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chromoblastomycosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chromoblastomycosis
CDC on Chromoblastomycosis
Chromoblastomycosis in the news
Blogs on Chromoblastomycosis
Directions to Hospitals Treating Chromoblastomycosis
Risk calculators and risk factors for Chromoblastomycosis

This page is about clinical aspects of the disease.  For microbiologic aspects of the causative organism(s), see Fonsecaea pedrosoi.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies

Case Studies

Case#1